Publications by authors named "Bao-wen Qi"

Article Synopsis
  • Patients with diabetes are more susceptible to myocardial ischemia/reperfusion injury (MI/RI), and Shuxin decoction (SXT), a modified herbal formula, has shown promise in reducing this risk in clinical settings, though its mechanisms are not fully understood.
  • The study aims to explore how SXT mitigates MI/RI in diabetic patients using an ensemble model that combines network pharmacology and biology, identifying key components and therapeutic targets associated with the condition.
  • Results indicate that SXT may improve lipid metabolism and reduce apoptosis in MI/RI by decreasing oxidized LDL levels and targeting the RAGE signaling pathway, with animal trials supporting these findings through observed reductions in harmful substances and regulation of blood lipid levels.
View Article and Find Full Text PDF

Background: To investigate the burden of thyroid cancer and its attributable risk factors in 204 countries and territories during 30 years.

Methods: We extracted data from the Global Burden of Disease (GBD) 2019 database, including incidence, mortality, disability-adjusted life-years (DALYs), and the attributable risk factors of thyroid cancer from 1990 to 2019. Estimated annual percentage changes (EAPC) were calculated to assess the changes in age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR).

View Article and Find Full Text PDF

Phosphoinositide 3-kinase-gamma (PI3Kgamma) has been identified to play the critical roles in inflammatory cells activation and recruitment in multiply inflammatory diseases and it promised to be a prospective target for relevant inflammatory diseases therapy. AS605240, a selective PI3Kgamma inhibitor, has been proved effective on several inflammatory diseases. In this study, we investigated the protective effect of AS605240 on bleomycin-induced pulmonary fibrosis in rats.

View Article and Find Full Text PDF